Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

Research output: Contribution to journalArticle

Standard

Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis. / Fisher, Benjamin A; Plant, Darren; Brode, Monica; van Vollenhoven, Ronald F; Mathsson, Linda; Symmons, Deborah; Lundberg, Karin; Rönnelid, Johan; Venables, Patrick J.

In: Annals of the Rheumatic Diseases, Vol. 70, No. 6, 2011, p. 1095-8.

Research output: Contribution to journalArticle

Harvard

Fisher, BA, Plant, D, Brode, M, van Vollenhoven, RF, Mathsson, L, Symmons, D, Lundberg, K, Rönnelid, J & Venables, PJ 2011, 'Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis', Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1095-8. https://doi.org/10.1136/ard.2010.138909

APA

Fisher, B. A., Plant, D., Brode, M., van Vollenhoven, R. F., Mathsson, L., Symmons, D., Lundberg, K., Rönnelid, J., & Venables, P. J. (2011). Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis. Annals of the Rheumatic Diseases, 70(6), 1095-8. https://doi.org/10.1136/ard.2010.138909

Vancouver

Author

Fisher, Benjamin A ; Plant, Darren ; Brode, Monica ; van Vollenhoven, Ronald F ; Mathsson, Linda ; Symmons, Deborah ; Lundberg, Karin ; Rönnelid, Johan ; Venables, Patrick J. / Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis. In: Annals of the Rheumatic Diseases. 2011 ; Vol. 70, No. 6. pp. 1095-8.

Bibtex

@article{d84849edb751425a85a29e62ea766e24,
title = "Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis",
abstract = "The anticyclic citrullinated peptide 2 (anti-CCP2) assay is a generic test for antibodies to citrullinated proteins, among which there is a subset of about 50% with antibodies to citrullinated enolase peptide 1 (CEP-1). The anti-CEP-1 positive subset is strongly associated with the HLA-DRB1 shared epitope and its interaction with smoking.",
author = "Fisher, {Benjamin A} and Darren Plant and Monica Brode and {van Vollenhoven}, {Ronald F} and Linda Mathsson and Deborah Symmons and Karin Lundberg and Johan R{\"o}nnelid and Venables, {Patrick J}",
year = "2011",
doi = "10.1136/ard.2010.138909",
language = "English",
volume = "70",
pages = "1095--8",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

AU - Fisher, Benjamin A

AU - Plant, Darren

AU - Brode, Monica

AU - van Vollenhoven, Ronald F

AU - Mathsson, Linda

AU - Symmons, Deborah

AU - Lundberg, Karin

AU - Rönnelid, Johan

AU - Venables, Patrick J

PY - 2011

Y1 - 2011

N2 - The anticyclic citrullinated peptide 2 (anti-CCP2) assay is a generic test for antibodies to citrullinated proteins, among which there is a subset of about 50% with antibodies to citrullinated enolase peptide 1 (CEP-1). The anti-CEP-1 positive subset is strongly associated with the HLA-DRB1 shared epitope and its interaction with smoking.

AB - The anticyclic citrullinated peptide 2 (anti-CCP2) assay is a generic test for antibodies to citrullinated proteins, among which there is a subset of about 50% with antibodies to citrullinated enolase peptide 1 (CEP-1). The anti-CEP-1 positive subset is strongly associated with the HLA-DRB1 shared epitope and its interaction with smoking.

U2 - 10.1136/ard.2010.138909

DO - 10.1136/ard.2010.138909

M3 - Article

C2 - 21367760

VL - 70

SP - 1095

EP - 1098

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -